Hints on ATGL implications in cancer: beyond bioenergetic clues

Cell Death & Disease
Rolando VeglianteMaria Rosa Ciriolo

Abstract

Among metabolic rearrangements occurring in cancer cells, lipid metabolism alteration has become a hallmark, aimed at sustaining accelerated proliferation. In particular, fatty acids (FAs) are dramatically required by cancer cells as signalling molecules and membrane building blocks, beyond bioenergetics. Along with de novo biosynthesis, free FAs derive from dietary sources or from intracellular lipid droplets, which represent the storage of triacylglycerols (TAGs). Adipose triglyceride lipase (ATGL) is the rate-limiting enzyme of lipolysis, catalysing the first step of intracellular TAGs hydrolysis in several tissues. However, the roles of ATGL in cancer are still neglected though a putative tumour suppressor function of ATGL has been envisaged, as its expression is frequently reduced in different human cancers (e.g., lung, muscle, and pancreas). In this review, we will introduce lipid metabolism focusing on ATGL functions and regulation in normal cell physiology providing also speculative perspectives on potential non-energetic functions of ATGL in cancer. In particular, we will discuss how ATGL is implicated, mainly through the peroxisome proliferator-activated receptor-α (PPAR-α) signalling, in inflammation, redox homoeosta...Continue Reading

References

Feb 18, 1997·Proceedings of the National Academy of Sciences of the United States of America·G BarbaC Bréchot
Jan 24, 2002·Proceedings of the National Academy of Sciences of the United States of America·Jack L ArbiserJ David Lambeth
Oct 3, 2002·Nature Reviews. Immunology·Raymond A Daynes, Dallas C Jones
Dec 20, 2002·Nature·Lisa M Coussens, Zena Werb
Jun 18, 2003·The Journal of Cell Biology·Carole SztalrydConstantine Londos
Jul 28, 2004·Archives of Dermatological Research·Maja GrabackaAndrzej Slominski
Aug 5, 2004·The Journal of Biological Chemistry·Vidya SubramanianDawn L Brasaemle
Oct 12, 2004·Biochemical and Biophysical Research Communications·Tetsuya ToyamaTakeshi Okanoue
Nov 20, 2004·Science·Robert ZimmermannRudolf Zechner
Apr 22, 2006·Contributions to Microbiology·Karin E de Visser, Lisa M Coussens
May 19, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Maja GrabackaKrzysztof Reiss
Sep 19, 2006·The International Journal of Biochemistry & Cell Biology·Marian ValkoJoshua Telser
Sep 19, 2006·Current Biology : CB·Silvia CermelliMichael A Welte
Jan 7, 2009·PPAR Research·Liliane Michalik, Walter Wahli
Apr 3, 2009·Molecular Biology of the Cell·Jun-Sub KimGary M Bokoch
Apr 3, 2009·Nature·Rajat SinghMark J Czaja
Apr 30, 2009·American Journal of Physiology. Endocrinology and Metabolism·Martina SchweigerRudolf Zechner
May 27, 2009·Carcinogenesis·Francesco ColottaAlberto Mantovani
Aug 6, 2009·Annual Review of Genetics·Congcong He, Daniel J Klionsky
Sep 3, 2009·The Journal of Biological Chemistry·Petra C KienesbergerErin E Kershaw
Jan 20, 2010·FEBS Letters·Xingyuan YangJun Liu
Feb 6, 2010·Biochemical and Biophysical Research Communications·Masahiro ShibataYasuo Uchiyama
Apr 28, 2010·Proceedings of the National Academy of Sciences of the United States of America·Frank WeinbergNavdeep S Chandel
Apr 29, 2010·The Journal of Biological Chemistry·Prakash G ChandakDagmar Kratky
Jul 20, 2010·Autophagy·Giuseppe FilomeniMaria Rosa Ciriolo
Oct 23, 2010·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Kuok Teong OngDouglas G Mashek
Jan 5, 2011·The Journal of Biological Chemistry·Elma AflakiDagmar Kratky
Mar 12, 2011·The Journal of Biological Chemistry·Hong WangCarole Sztalryd
Apr 6, 2011·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Jiang Wei WuGrant A Mitchell
May 3, 2011·Cellular and Molecular Life Sciences : CMLS·Elma AflakiDagmar Kratky
Aug 23, 2011·Nature Medicine·Guenter HaemmerleRudolf Zechner
Nov 1, 2011·Immunity·Ali KuraishySergei I Grivennikov
Jan 20, 2012·Experimental & Molecular Medicine·Kyeong Sook Choi

❮ Previous
Next ❯

Citations

Apr 14, 2019·Nutrients·Luana TomaipitincaClaudia Giampietri
Feb 16, 2020·Nutrients·Dalia M KopustinskieneJurga Bernatoniene
Aug 8, 2018·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Toni PetanMaida Jusović
Dec 19, 2019·Frontiers in Oncology·Wei LuJie Ma
Jun 18, 2019·Oxidative Medicine and Cellular Longevity·Fabio CiccaroneMaria Rosa Ciriolo
Jan 31, 2020·Frontiers in Oncology·Luca Di LeoDaniela De Zio
May 30, 2019·Frontiers in Oncology·Monica NeaguAristidis M Tsatsakis
Dec 22, 2019·Scientific Reports·Bouchra TaïbRexford S Ahima
Mar 12, 2020·Clinical Sarcoma Research·Anastassia SerguienkoOla Myklebost
Jul 17, 2019·Molecular Cancer Research : MCR·Matthew J VandeKoppleIoanna Papandreou
Nov 22, 2020·The Journal of Biological Chemistry·Guohua ChenJian Wang
Jul 2, 2020·Trends in Cancer·Camille Attané, Catherine Muller
Dec 29, 2020·Frontiers in Oncology·Wenjun WangJiuwei Cui
Jan 9, 2021·Cancer & Metabolism·Shilpa R NagarajanAndrew J Hoy
Feb 24, 2021·Journal of Cellular and Molecular Medicine·Haofan YinHonghai Hong
Mar 9, 2020·Seminars in Cell & Developmental Biology·Marta BoschAlbert Pol
Jan 19, 2021·The Journal of Biological Chemistry·Guohua ChenJian Wang
Jul 28, 2020·Advanced Drug Delivery Reviews·Lisa M ButlerJohannes V Swinnen
Nov 7, 2021·Cancer Metastasis Reviews·Gioia HeraviWanqing Liu

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsies

Related Concepts

Related Feeds

Parkinson's Disease & Autophagy (MDS)

Autophagy leads to degradation of damaged proteins and organelles by the lysosome. Impaired autophagy has been implicated in several diseases. Here is the role of autophagy in Parkinson’s disease.

Cancer Metabolic Reprogramming (Keystone)

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.

Cancer Metabolic Reprogramming

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.

Autophagy & Model Organisms

Autophagy is a cellular process that allows degradation by the lysosome of cytoplasmic components such as proteins or organelles. Here is the latest research on autophagy & model organisms

Cancer Metabolism

In order for cancer cells to maintain rapid, uncontrolled cell proliferation, they must acquire a source of energy. Cancer cells acquire metabolic energy from their surrounding environment and utilize the host cell nutrients to do so. Here is the latest research on cancer metabolism.

Autophagy & Metabolism

Autophagy preserves the health of cells and tissues by replacing outdated and damaged cellular components with fresh ones. In starvation, it provides an internal source of nutrients for energy generation and, thus, survival. A powerful promoter of metabolic homeostasis at both the cellular and whole-animal level, autophagy prevents degenerative diseases. It does have a downside, however--cancer cells exploit it to survive in nutrient-poor tumors.

Autophagy & Disease

Autophagy is an important cellular process for normal physiology and both elevated and decreased levels of autophagy are associated with disease. Here is the latest research.